Cory Doctorow argues at The Guardian that all, not just publicly funded, pharmaceutical research should be made open access. Many people, he says, agree that all publicly funded research should be available to the public — the main argument being that since the public funded it, they should be able to see the result. But Doctorow goes a step further.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.